Cargando…
Synthetic Lethality Screening Highlights Colorectal Cancer Vulnerability to Concomitant Blockade of NEDD8 and EGFR Pathways
SIMPLE SUMMARY: Identification of effective therapies for clinically aggressive, treatment-resistant colorectal cancer (CRC) remains an unmet clinical need. Targeted therapies against the epidermal growth factor receptor (EGFR) signaling axis lead to clinical benefits only in a small fraction of pat...
Autores principales: | Invrea, Federica, Punzi, Simona, Petti, Consalvo, Minelli, Rosalba, Peoples, Michael D., Bristow, Christopher A., Vurchio, Valentina, Corrado, Alessia, Bragoni, Alberto, Marchiò, Caterina, Bertotti, Andrea, Trusolino, Livio, Bardelli, Alberto, Isella, Claudio, Carugo, Alessandro, Draetta, Giulio F., Medico, Enzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8345131/ https://www.ncbi.nlm.nih.gov/pubmed/34359705 http://dx.doi.org/10.3390/cancers13153805 |
Ejemplares similares
-
A diphtheria toxin resistance marker for in vitro and in vivo selection of stably transduced human cells
por: Picco, Gabriele, et al.
Publicado: (2015) -
Case report: Preclinical efficacy of NEDD8 and proteasome inhibitors in patient-derived models of signet ring high-grade mucinous colorectal cancer from a Lynch syndrome patient
por: Torchiaro, Erica, et al.
Publicado: (2023) -
Selective analysis of cancer-cell intrinsic transcriptional traits defines novel clinically relevant subtypes of colorectal cancer
por: Isella, Claudio, et al.
Publicado: (2017) -
Loss of AXIN1 drives acquired resistance to WNT pathway blockade in colorectal cancer cells carrying RSPO3 fusions
por: Picco, Gabriele, et al.
Publicado: (2017) -
MicroRNA–mRNA interactions underlying colorectal cancer molecular subtypes
por: Cantini, Laura, et al.
Publicado: (2015)